CR2 and acute lymphoblastic leukemia: Furthermore, we show that anti-CD21 CAR-T efficacy can be enhanced through phosphatidylinositol 3-kinase (PI3K)–mediated pharmacological up-regulation of CD21 antigen density, representing a promising potential treatment strategy for patients with T-ALL.